Journal of Psychopharmacology

JournalCitation impact & published research

Journal of Psychopharmacology is a journal indexed in ScholarIQ from OpenAlex. ScholarIQ records 4,686 works, 179,593 citations and an h-index of 169.

4,686

Works

179,593

Citations

169

h-index

IDs:OpenAlex

What are the most-cited papers on Journal of Psychopharmacology?

ScholarIQmost cited works

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Roland R. Griffiths, Matthew W. Johnson, Michael A. Carducci, Annie Umbricht, William A. Richards, Brian D. Richards, Mary P Cosimano, Margaret A. Klinedinst

Journal of Psychopharmacology. 20162,197 CitationsOPEN ACCESS

Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology

GM Goodwin, Peter Haddad, I. Nicol Ferrier, JK Aronson, TRH Barnes, Andrea Cipriani, David Coghill, Seena Fazel, John Geddes, Heinz Grunze, Emily A. Holmes, Oliver Howes, Stephen M. Hudson, Neil Hunt, Ian Jones, I. C. MacMillan, R. Hamish McAllister‐Williams, DR Miklowitz, Richard Morriss, Marcus R. Munafò, Carol Paton, Barbara J. Sahakian, KEA Saunders, JMA Sinclair, David Taylor, Eduard Vieta, Allan H. Young

Journal of Psychopharmacology. 20161,303 CitationsOPEN ACCESS

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

Anthony J. Cleare, Carmine M. Pariante, Allan H. Young, Ian Anderson, David Christmas, Philip J. Cowen, Chris Dickens, I. Nicol Ferrier, John Geddes, Simon Gilbody, Peter Haddad, Cornelius Katona, Glyn Lewis, Andrea L. Malizia, R. Hamish McAllister‐Williams, Paul Ramchandani, Jan Scott, David Taylor, Rudolf Uher, the members of the Consensus Meeting

Journal of Psychopharmacology. 2015767 CitationsOPEN ACCESS

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

David S. Baldwin, Ian Anderson, David Nutt, Christer Allgulander, Borwin Bandelow, Johan A. den Boer, David Christmas, Simon Davies, Naomi Fineberg, Nicky Lidbetter, Andrea L. Malizia, Paul McCrone, Daniel Nabarro, Catherine O’Neill, Jan Scott, Nic J.A. van der Wee, Hans‐Ulrich Wïttchen

Journal of Psychopharmacology. 2014677 CitationsOPEN ACCESS

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

Teri Suzanne Krebs, Pål-Ørjan Johansen

Journal of Psychopharmacology. 2012583 Citations

Related on ScholarIQ

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Paper

Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology

Paper

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

Paper

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

Paper

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report

Paper